Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
15.8%EBITDA Margin
VS
Market
Sector
Industry
History
$ 6.63Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information
Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMUCELL CORP - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ICCC - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 4.47M | 15.8% | $ 28.27M |
| 3/31/2025 | $ 2.43M | 8.92% | $ 27.3M |
| 12/31/2024 | $ 540.61K | 2.04% | $ 26.49M |
| 9/30/2024 | $ -1.12M | -4.69% | $ 23.84M |
| 6/30/2024 | $ -1.33M | -5.73% | $ 23.22M |
| 3/31/2024 | $ -1.17M | -5.48% | $ 21.28M |
| 12/31/2023 | $ -3.05M | -17.47% | $ 17.47M |
| 9/30/2023 | $ -3.65M | -22.42% | $ 16.29M |
| 6/30/2023 | $ -3.43M | -21.87% | $ 15.69M |
| 3/31/2023 | $ -2.79M | -17.43% | $ 16.01M |
Key Performance Insights, Last 5 Years
- IMMUCELL CORP's latest trailing twelve months (TTM) EBITDA % stands at 4.96%.
- Over the past 5 years, IMMUCELL CORP's average EBITDA % has been 1.55%.
- The median EBITDA % for IMMUCELL CORP during this period was 6.16%
- IMMUCELL CORP reached its highest EBITDA % over the past 5 years at 16.9%.
- The lowest EBITDA % recorded by IMMUCELL CORP in the same timeframe -22.42%
IMMUCELL CORP's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for IMMUCELL CORP is calculated as follows: EBITDA [ $ 756.11K ] / Revenues [ $ 15.23M ]
(=) EBITDA % [ 4.96% ] ICCC - EBITDA Margin, Last 5 years
-22.42%
Minimum
Sep 30, 2023
16.9%
Maximum
Mar 31, 2022
1.55%
Average
6.16%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.15% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.98% |
| max | 97.73% |
| average | 16.15% |
| median | 14.67% |
| std | 26.84% |